other material
confidence high
sentiment positive
materiality 0.75
AtaiBeckley reports positive Phase 2a results for EMP-01 in Social Anxiety Disorder; LSAS -11.85 vs placebo
AtaiBeckley Inc.
- EMP-01 met primary safety objective; no serious AEs, no suicidal behavior.
- LSAS placebo-adjusted reduction of 11.85 points at Day 43 (Hedges' g=0.45, p=0.036 one-tailed).
- CGI-I responders: 49% EMP-01 vs 15% placebo; NNT 2.95.
- Improvements in both Fear (-13.7) and Avoidance (-15.1) subscales after two doses without psychotherapy.
- 71 patients enrolled, 69 completed Day 43 with high retention.